Life Course & Population Sciences

Activities

Activities per year 1982 2001 2025

• 333 Participation in conference
• 255 Publication peer-review
• 108 Invited talk
• 104 Types of External academic engagement - Contribution to the work of national or international committees and working groups
• 581 More
  • 96 Types of External academic engagement - Membership of external research organisation
  • 76 Editorial activity
  • 61 Membership of committee
  • 60 Types of Public engagement and outreach - Media article or participation
  • 52 Oral presentation
  • 44 Types of External academic engagement - Membership of peer review panel or committee
  • 36 Types of Business and Community - Work on advisory panel to industry or government or non-government organisation
  • 30 Types of External academic engagement - Invited talk
  • 27 Participation in workshop, seminar, course
  • 26 Membership of board
  • 13 Other
  • 12 Membership of network
  • 8 Types of Public engagement and outreach - Public lecture/debate/seminar
  • 6 Examination
  • 6 Types of External academic engagement - Research and Teaching at External Organisation
  • 5 Types of Award - Prize (including medals and awards)
  • 5 Types of Business and Community - Membership of public/government advisory/policy group or panel
  • 4 Types of Award - Fellowship awarded competitively
  • 4 Types of Public engagement and outreach - Festival/Exhibition
  • 2 Types of External academic engagement - Hosting an academic visitor
  • 2 Types of Public engagement and outreach - Schools engagement
  • 2 Types of Public engagement and outreach - Work on advisory panels for social community and cultural engagement
  • 1 Consultancy
  • 1 Types of Award - Other distinction
  • 1 Types of Business and Community - CPD delivery/organisation of courses for externals (in kind)
  • 1 Visiting an external academic institution

Activities per year

Search results

• Vitreoretinal disease

  Jackson, T. (Speaker)

  20 May 2025

  Activity: Talk or presentation › Oral presentation

• Role of VEGF-C and D inhibition in AMD

  Jackson, T. (Invited speaker)

  20 Sept 2024

  Activity: Talk or presentation › Oral presentation

• Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial

  Jackson, T. (Invited speaker)

  19 Sept 2024

  Activity: Talk or presentation › Oral presentation

• VEGF-A/-C/-D inhibition with sozinibercept and ranibizumab combination therapy for nAMD: subgroup analysis of a phase 2b study to assess the angiographic predictors of response

  Jackson, T. (Speaker)

  19 Sept 2024

  Activity: Talk or presentation › Oral presentation

• Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial

  Jackson, T. (Speaker)

  15 Sept 2024

  Activity: Talk or presentation › Oral presentation

• Eating on the Night Shift: What is important to UK night workers when designing nutritional research?

  Gibson, R. (Speaker)

  26 Mar 2024

  Activity: Talk or presentation › Oral presentation

• How are hospitals in England caring for women at risk of preterm birth in light of Saving Babies Lives Care Bundle v2 Element 5, and can we develop the midwife role here?

  Carlisle, N. (Speaker)

  28 Mar 2023

  Activity: Talk or presentation › Oral presentation

• Results of Part A of KALAHARI, a Phase 2 Trial of THR-149, a plasma kallikrein inhibitor, for the treatment of diabetic macular oedema

  Jackson, T. (Speaker)

  2 Sept 2022

  Activity: Talk or presentation › Oral presentation

• Designing, executing and interpreting randomised clinical trials

  Jackson, T. (Invited speaker)

  2 Sept 2022

  Activity: Talk or presentation › Oral presentation

• How are hospitals in England caring for women at risk of preterm birth? The influence of national guidance on preterm birth care in England

  Carlisle, N. (Speaker)

  15 Nov 2021

  Activity: Talk or presentation › Oral presentation

• Caring for women who arrive in threatened preterm labor

  Carlisle, N. (Speaker)

  24 May 2021

  Activity: Talk or presentation › Oral presentation

• Development and implementation of hypertension in pregnancy decision aids

  Chappell, L. (Speaker)

  Nov 2020

  Activity: Talk or presentation › Oral presentation

• Placental magnetic resonance imaging in pre-eclampsia

  Chappell, L. (Speaker)

  Nov 2020

  Activity: Talk or presentation › Oral presentation

• Coordinating Mental Health Act assessments

  Stevens, M. (Speaker), Martineau, S. (Speaker), Bramley, S. (Speaker), Steils, N. (Speaker) & Manthorpe, J. (Speaker)

  8 Oct 2020

  Activity: Talk or presentation › Oral presentation

• Designing, executing and interpreting randomized clinical trials

  Jackson, T. (Speaker)

  2 Oct 2020

  Activity: Talk or presentation › Oral presentation

• Placenta biomarkers in chronic kidney disease and chronic hypertension

  Chappell, L. (Speaker)

  Sept 2020

  Activity: Talk or presentation › Oral presentation

• Vitrectomy, subretinal TPA and gas for submacular haemorrhage due to wet AMD

  Jackson, T. (Keynote speaker)

  14 Feb 2020

  Activity: Talk or presentation › Oral presentation

• Genetic Risk of Rheumatoid Arthritis is Associated with the Oral and Gut Microbiota

  Wells, P. (Speaker)

  7 Oct 2019

  Activity: Talk or presentation › Oral presentation

• UDCA vs. placebo in women with intrahepatic cholestasis of pregnancy

  Chappell, L. (Speaker)

  Jun 2019

  Activity: Talk or presentation › Oral presentation

• Neonatal outcomes in the PHOENIX trial

  Chappell, L. (Speaker)

  Jun 2019

  Activity: Talk or presentation › Oral presentation

• Planned delivery or expectant management for late preterm pre-eclampsia

  Chappell, L. (Speaker)

  Jun 2019

  Activity: Talk or presentation › Oral presentation

• EFFICACY OF VAGINAL CERCLAGE IN WOMEN WITH PRIOR EMERGENCY CAESAREAN SECTION

  Glazewska-Hallin, A.G.-H. (Speaker)

  15 Mar 2019

  Activity: Talk or presentation › Oral presentation

• Will she deliver preterm? Using quantitative fetal fibronectin levels to help you make clinical decisions

  Carlisle, N. (Speaker)

  28 Nov 2018 → 25 Jun 2019

  Activity: Talk or presentation › Oral presentation

• Can common characteristics be identified as predictors for seasonal influenza vaccine uptake in pregnancy? A retrospective cohort study from a South London Hospital.

  Carlisle, N. (Speaker)

  23 Oct 2018

  Activity: Talk or presentation › Oral presentation

• Adverse perinatal outcomes in ICP and association with biochemical markers

  Chappell, L. (Speaker)

  Oct 2018

  Activity: Talk or presentation › Oral presentation

• Created of an animated film for use as a training tool for Healthcare Professionals involved in the EQUIPTT study

  Carlisle, N. (Speaker)

  14 Sept 2018

  Activity: Talk or presentation › Oral presentation

• An Audit of Threatened Preterm Labour Management across 13 Obstetric Sites

  Carlisle, N. (Speaker)

  14 Sept 2018

  Activity: Talk or presentation › Oral presentation

• The alternative Mediterranean diet score and blood pressure: A cross-sectional study of US participants in the INTERMAP Study

  Gibson, R. (Speaker)

  11 Jun 2018

  Activity: Talk or presentation › Oral presentation

• Will she deliver preterm? Using quantitative fetal fibronectin levels to assess risk

  Carlisle, N. (Speaker)

  23 May 2018

  Activity: Talk or presentation › Oral presentation

• The PHOENIX trial: timing of delivery in late preterm pre-eclampsia

  Chappell, L. (Speaker)

  Mar 2018

  Activity: Talk or presentation › Oral presentation

• The PITCHES trial: UDCA for intrahepatic cholestasis of pregnancy

  Chappell, L. (Speaker)

  Mar 2018

  Activity: Talk or presentation › Oral presentation

• Vascular function in women with chronic hypertension in pregnancy

  Chappell, L. (Speaker)

  Nov 2017

  Activity: Talk or presentation › Oral presentation

• Incidence of preeclampsia in the UK in 2016-17

  Chappell, L. (Speaker)

  Sept 2017

  Activity: Talk or presentation › Oral presentation

• Pregnancy And chronic hypertension – NifeDipine vs lAbetalol as antihypertensive treatment trial

  Chappell, L. (Speaker)

  Oct 2016

  Activity: Talk or presentation › Oral presentation

• Sex differences in the relationship between work patterns and diet in British police force employees: a nested cross-sectional study

  Gibson, R. (Speaker)

  8 Dec 2015

  Activity: Talk or presentation › Oral presentation

• Urinary congophilia in women with preeclampsia and chronic kidney disease

  Chappell, L. (Speaker)

  Sept 2015

  Activity: Talk or presentation › Oral presentation

• Ethnic variation in outcomes in chronic hypertension in pregnancy

  Chappell, L. (Speaker)

  Jun 2015

  Activity: Talk or presentation › Oral presentation

• Endothelial surface layer and renal markers in superimposed pre-eclampsia

  Chappell, L. (Speaker)

  Apr 2015

  Activity: Talk or presentation › Oral presentation

• Third trimester biomarkers for prediction of small for gestational age infants: the PELICAN studies

  Chappell, L. (Speaker)

  Oct 2014

  Activity: Talk or presentation › Oral presentation

• The impact of shift work on nutrient intake and metabolic risk: methodological issues

  Gibson, R. (Speaker)

  25 Feb 2014

  Activity: Talk or presentation › Oral presentation

• PlGF and other biomarkers in women with suspected pre-eclampsia prior to 35 weeks' gestation

  Chappell, L. (Speaker)

  Jun 2013

  Activity: Talk or presentation › Oral presentation

• Obstetric outcomes and management of labour and delivery in inherited bleeding disorders

  Chappell, L. (Speaker)

  May 2013

  Activity: Talk or presentation › Oral presentation

• Plasma PlGF measurement in women presenting with suspected pre-eclampsia: the PELICAN study

  Chappell, L. (Speaker)

  Jul 2012

  Activity: Talk or presentation › Oral presentation

• PITCH: Two randomised controlled trials in obstetric cholestasis

  Chappell, L. (Speaker)

  Jun 2011

  Activity: Talk or presentation › Oral presentation

• Ursodeoxycholic acid vs. placebo in women with obstetric cholestasis

  Chappell, L. (Speaker)

  May 2011

  Activity: Talk or presentation › Oral presentation

• Urinary proteomics for the prediction of pre-eclampsia

  Chappell, L. (Speaker)

  Sept 2008

  Activity: Talk or presentation › Oral presentation

• Adverse perinatal outcomes and risk factors for pre-eclampsia in women with chronic hypertension

  Chappell, L. (Speaker)

  Jun 2008

  Activity: Talk or presentation › Oral presentation

• Why do vitamins C and E not prevent pre-eclampsia?

  Chappell, L. (Speaker)

  Mar 2007

  Activity: Talk or presentation › Oral presentation

• Reduction in occurrence of pre-eclampsia with antioxidants is associated with decreased 8-epi-PGF2

  Chappell, L. (Speaker)

  Mar 2000

  Activity: Talk or presentation › Oral presentation

• Prophylactic antioxidant supplementation decreases the occurrence of pre-eclampsia

  Chappell, L. (Speaker)

  Dec 1999

  Activity: Talk or presentation › Oral presentation